Literature DB >> 23640982

Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus.

P Rianthavorn1, C Chokedeemeeboon, T Deekajorndech, K Suphapeetiporn.   

Abstract

Interleukin (IL)-10 expression is regulated by its promoter and correlated with the activity of adult-onset lupus (systemic lupus erythematosus (SLE)). As the pathogenesis of adult-onset SLE may differ from SLE with the age at onset <18 years old (juvenile SLE or JSLE), we evaluated polymorphisms at positions -1082A/G, -819T/C and -592A/C of the IL-10 promoter and serum IL-10 levels in 71 patients with JSLE. Disease activity was determined by the SLE disease activity index (SLEDAI). Active SLE was defined by SLEDAI ≥ 6 and inactive SLE was defined by SLEDAI equal to zero. The mean age was 14.5 ± 2.8 years. Nephritis occurred in 57 patients. In JSLE patients, -592 CC and -819 CC were identified with a higher frequency than in controls with the odds ratio (OR) of 2.75 (95% confidence interval (CI) 1.11-6.81, p = 0.04). GCC increased the susceptibility to nephritis in patients with JSLE (OR 2.16, 95% CI 1.07-4.35, p = 0.03). Serum IL-10 levels were significantly higher in 20 JSLE patients with active disease than in 27 patients with inactive disease and in 15 healthy children (p < 0.001). In conclusion, IL-10 expression was upregulated in active JSLE. The -819 CC and -592 CC genotypes increased the susceptibility to JSLE and GCC increased the susceptibility to nephritis.

Entities:  

Keywords:  Interleukin-10; juvenile systemic lupus erythematosus; single-nucleotide polymorphisms

Mesh:

Substances:

Year:  2013        PMID: 23640982     DOI: 10.1177/0961203313486192

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  6 in total

1.  Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus.

Authors:  Arezou Rezaei; Vahid Ziaee; Fatemeh Tahghighi Sharabian; Sara Harsini; Maryam Mahmoudi; Samaneh Soltani; Maryam Sadr; Mohammad Hassan Moradinejad; Yahya Aghighi; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2015-01-30       Impact factor: 2.980

2.  Immunogenetics of Lupus Erythematosus.

Authors:  Begüm Ünlü; Ümit Türsen; Navid Jabalameli; Fahimeh Abdollahimajd; Fateme Rajabi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Cytokine profile in childhood-onset systemic lupus erythematosus: a cross-sectional and longitudinal study.

Authors:  A Cavalcanti; R Santos; Z Mesquita; A L B P Duarte; N Lucena-Silva
Journal:  Braz J Med Biol Res       Date:  2017-04-03       Impact factor: 2.590

Review 4.  Systemic Lupus Erythematosus in Children and Young People.

Authors:  A Charras; E Smith; C M Hedrich
Journal:  Curr Rheumatol Rep       Date:  2021-02-10       Impact factor: 4.592

5.  Impact of IL-10 gene polymorphisms and its interaction with environment on susceptibility to systemic lupus erythematosus.

Authors:  Gui-Hong Wang; Ting Zuo; Zheng-Cai Zuo
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

Review 6.  Biological Role, Mechanism of Action and the Importance of Interleukins in Kidney Diseases.

Authors:  Paulina Mertowska; Sebastian Mertowski; Iwona Smarz-Widelska; Ewelina Grywalska
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.